AP-1 Function and Regulation
Overview
Affiliations
AP-1 (activating protein-1) is a collective term referring to dimeric transcription factors composed of Jun, Fos or ATF (activating transcription factor) subunits that bind to a common DNA site, the AP-1-binding site. As the complexity of our knowledge of AP-1 factors has increased, our understanding of their physiological function has decreased. This trend, however, is beginning to be reversed due to the recent studies of gene-knockout mice and cell lines deficient in specific AP-1 components. Such studies suggest that different AP-1 factors may regulate different target genes and thus execute distinct biological functions. Also, the involvement of AP-1 factors in functions such as cell proliferation and survival has been made somewhat clearer as a result of such studies. In addition, there has been considerable progress in understanding some of the mechanisms and signaling pathways involved in the regulation of AP-1 activity. In addition to regulation by heterodimerization between Jun, Fos and ATF proteins, AP-1 activity is regulated through interactions with specific protein kinases and a variety of transcriptional coactivators.
Silva A, de Lavor M Int J Mol Sci. 2025; 26(5).
PMID: 40076672 PMC: 11900433. DOI: 10.3390/ijms26052050.
CTCF/RAD21 organize the ground state of chromatin-nuclear speckle association.
Yu R, Roseman S, Siegenfeld A, Gardner Z, Nguyen S, Tran K Nat Struct Mol Biol. 2025; .
PMID: 39984730 DOI: 10.1038/s41594-024-01465-6.
Hou L, Yang J, Li Y, Kang J, Ma Z, Luo X Medicine (Baltimore). 2025; 104(7):e41496.
PMID: 39960917 PMC: 11835136. DOI: 10.1097/MD.0000000000041496.
Proteomic meta-analysis unveils new frontiers for biomarkers research in pancreatic carcinoma.
Di Marco F, Cufaro M, Damiani V, Dufrusine B, Pizzinato E, Di Ferdinando F Oncogenesis. 2025; 14(1):3.
PMID: 39956821 PMC: 11830788. DOI: 10.1038/s41389-025-00547-4.
Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status.
Hu C, Chen Y, Yin X, Xu R, Yin C, Wang C Signal Transduct Target Ther. 2025; 10(1):39.
PMID: 39948335 PMC: 11825823. DOI: 10.1038/s41392-024-02098-3.